Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2012 | Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions | Lin Y.-Y.; Hsu Y.-H.; Huang H.-Y.; Shann Y.-J.; Huang C.-Y.F.; SHU-CHEN WEI ; CHI-LING CHEN ; TZUU-SHUH JOU | Journal of Clinical Investigation | 26 | 27 | |
1997 | Acute pancreatitis complicated by infarction of the spleen and spinal cord | SHU-CHEN WEI ; JIA-HORNG KAO ; Lee W.-Y.; Lin J.-T.; Wang T.-H. | Journal of the Formosan Medical Association | 5 | 2 | |
2007 | Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis | MING-CHU CHANG ; YU-TING CHANG ; TA-CHEN SU ; WEI-SHIUNG YANG ; CHI-LING CHEN ; YU-WEN TIEN ; PO-CHIN LIANG ; SHU-CHEN WEI ; Wong J.-M. | Pancreas | 60 | 54 | |
2011 | Alcoholic pancreatitis complicated by an intra-abdominal abscess | Weng M.-T.; Tsang Y.-M.; SHU-CHEN WEI | Gastroenterology | 0 | 0 | |
2023 | Anemia in inflammatory bowel disease course is associated with patients' worse outcome | Hsiao, Po-Yen; Weng, Meng-Tzu; Chang, Chin-Hao; Huang, Ling-Yun; CHIEN-CHIH TUNG ; Leong, Yew-Loong; MING-JIUM SHIEH ; Wong, Jau-Min; SHU-CHEN WEI | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | | |
2016 | Aptamer-based colorimetric detection of proteins using a branched DNA cascade amplification strategy and unmodified gold nanoparticles | Chang C.-C.; Chen C.-Y.; Chuang T.-L.; Wu T.-H.; SHU-CHEN WEI ; Liao H.; Lin C.-W. | Biosensors and Bioelectronics | 92 | 83 | |
2016 | Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease Consensus-Part 1) | Ooi C.J.; Makharia G.K.; Hilmi I.; Gibson P.R.; Fock K.M.; Ahuja V.; Ling K.L.; Lim W.C.; Thia K.T.; SHU-CHEN WEI ; Leung W.K.; Koh P.K.; Gearry R.B.; Goh K.L.; Ouyang Q.; Sollano J.; Manatsathit S.; de Silva H.J.; Rerknimitr R.; Pisespongsa P.; Abu Hassan M.R.; Sung J.; Hibi T.; Boey C.C.M.; Moran N.; Leong R.W.L.; on behalf of the Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease | Journal of Gastroenterology and Hepatology (Australia) | 92 | 77 | |
2010 | The Asia-Pacific consensus on ulcerative colitis | Ooi C.J.; Fock K.M.; Makharia G.K.; Goh K.L.; Ling K.L.; Hilmi I.; Lim W.C.; Kelvin T.; Gibson P.R.; Gearry R.B.; Ouyang Q.; Sollano J.; Manatsathit S.; Rerknimitr R.; SHU-CHEN WEI ; Leung W.K.; De Silva H.J.; Leong R.W. | Journal of Gastroenterology and Hepatology (Australia) | 141 | 118 | |
2016 | Asia-Pacific consensus statements on Crohn's disease. Part 2: Management | Ooi C.J.; Makharia G.K.; Hilmi I.; Gibson P.R.; Fock K.M.; Ahuja V.; Ling K.L.; Lim W.C.; Thia K.T.; SHU-CHEN WEI ; Leung W.K.; Koh P.K.; Gearry R.B.; Goh K.L.; Ouyang Q.; Sollano J.; Manatsathit S.; de Silva H.J.; Rerknimitr R.; Pisespongsa P.; Abu Hassan M.R.; Sung J.; Hibi T.; Boey C.C.M.; Moran N.; Leong R.W.L.; on behalf of the Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease | Journal of Gastroenterology and Hepatology (Australia) | 37 | 34 | |
2018 | Asian organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment | Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI ; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. | Intestinal Research | 21 | 0 | |
2018 | Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management | Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI ; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. | Journal of Gastroenterology and Hepatology (Australia) | 21 | 19 | |
2018 | Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management | Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI ; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. | Intestinal Research | 14 | 0 | |
2021 | Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia | Ran Z.; Wu K.; Matsuoka K.; Jeen Y.T.; SHU-CHEN WEI ; Ahuja V.; Chen M.; Hu P.-J.; Andoh A.; Kim H.J.; Yang S.-K.; Watanabe M.; Ng S.C.; Hibi T.; Hilmi I.N.; Suzuki Y.; Han D.S.; Leung W.K.; Sollano J.; Ooi C.J.; Qian J. | Journal of Gastroenterology and Hepatology (Australia) | 49 | 38 | |
2018 | Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment | Park, Dong Ii; Hisamatsu, Tadakazu; Chen, Minhu; Ng, Siew Chien; Ooi, Choon Jin; SHU-CHEN WEI ; Banerjee, Rupa; Hilmi, Ida Normiha; Jeen, Yoon Tae; Han, Dong Soo; Kim, Hyo Jong; Ran, Zhihua; Wu, Kaichun; Qian, Jiaming; Hu, Pin-Jin; Matsuoka, Katsuyoshi; Andoh, Akira; Suzuki, Yasuo; Sugano, Kentaro; Watanabe, Mamoru; Hibi, Toshifumi; Puri, Amarender S; Yang, Suk-Kyun | Journal of gastroenterology and hepatology | 13 | 12 | |
2020 | Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic | Ling K.L.; Hilmi I.; Raja Ali R.A.; Leong R.W.L.; Leung W.K.; Ng S.C.; Wu K.C.; Chen M.H.; Ran Z.H.; Hisamatsu T.; Ahuja V.; Makharia G.K.; Banerjee R.; SHU-CHEN WEI ; Wu D.C.; Pisespongsa P.; Ye B.D.; Sollano J.; Simadibrata M.; Chuah S.W.; Ooi C.J. | JGH Open | 15 | 12 | |
2009 | Association and differential role of PRSS1 and SPINK1 mutation in early-onset and late-onset idiopathic chronic pancreatitis in Chinese subjects | YU-TING CHANG ; SHU-CHEN WEI ; L P.-C.; YU-WEN TIEN ; I-SHIOW JAN ; Su Y.-N.; Wong J.-M.; MING-CHU CHANG | Gut | 31 | 28 | |
2008 | Association of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) mutation/variant/haplotype and Tumor Necrosis Factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis | YU-TING CHANG ; MING-CHU CHANG ; TA-CHEN SU ; PO-CHIN LIANG ; Su Y.-N.; Kuo C.-H.; SHU-CHEN WEI ; Wong J.-M. | Clinical Chemistry | 77 | 50 | |
2009 | Association of novel chymotrypsin C gene variations and haplotypes in patients with chronic pancreatitis in Chinese in Taiwan | MING-CHU CHANG ; YU-TING CHANG ; SHU-CHEN WEI ; PO-CHIN LIANG ; I-SHIOW JAN ; Su Y.-N.; Kuo C.-H.; Wong J.-M. | Pancreatology | 17 | 18 | |
2006 | Association of tumour necrosis factor α promoter haplotype with chronic pancreatitis [20] | MING-CHU CHANG ; YU-TING CHANG ; YU-WEN TIEN ; PO-CHIN LIANG ; SHU-CHEN WEI ; Wong J.-M. | Gut | 11 | 11 | |
2022 | Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease | Weng, Meng-Tzu; I-LUN SHIH ; CHIEN-CHIH TUNG ; Leong, Yew-Loong; MING-JIUM SHIEH ; Wang, Cheng-Yi; Wong, Jau-Min; YEN-HSUAN NI ; SHU-CHEN WEI | Intestinal research | 7 | 6 | |